Search Results

Crystal IS, an Asahi Kasei company, announced the successful serial production of 100 mm diameter single-crystal aluminum nitride substrates with 99% usable area, based on current requirements for UVC LEDs, with manufacturing to take place in the United States.

CATUG Inc. and Crystal Bio, a member of Crystal Pharmatech, announced a long-term strategic partnership to provide advanced nucleic acid-based drug analytical services.

Recently, Crystal Formulations Services, the CDMO Business Unit of Crystal Pharmatech has achieved a significant milestone by successfully passing the on-site audit conducted by the European Qualified Person, evaluating its GMP quality system and production facilities.

West Pharmaceutical Services, Inc. announced that it will unveil its new Daikyo Crystal Zenith® Nested Vials in Tub at the International Society for Cell and Gene Therapy Annual Meeting taking place in Vancouver, Canada from May 29- June 1.

Crystal Bio, an innovative spinout division of Crystal Pharmatech, is excited to announce Dr. Shiaw-Lin (Billy) Wu as its new co-founder and Chief Scientific Officer (CSO).

Crystal IS, an Asahi Kasei company, announced the successful production of a 4-inch diameter single-crystal aluminum nitride substrate.

Renexxion Ireland Limited (“Renexxion”), a private biopharmaceutical company committed to delivering innovative drugs to patients with high unmet need in gastrointestinal (“GI”) disorders, announced today that the United States Patent Office (“USPTO”) has issued a new composition of matter patent (Patent no. 11,643,409) and a method of use patent (Patent no. 11,827,631), both covering a novel crystal isoform of naronapride.

Terran Biosciences (“Terran”), a biotech platform company dedicated to the development of transformational therapeutics for neurological and psychiatric diseases, has announced the publication of a PCT patent application covering what may be the first new salts, co-crystals, and polymorphs of psilocybin in history.